Cargando…
Cardiac Metabolism in Sepsis
The mechanism of sepsis-induced cardiac dysfunction is believed to be different from that of myocardial ischemia. In sepsis, chemical mediators, such as endotoxins, cytokines, and nitric oxide, cause metabolic abnormalities, mitochondrial dysfunction, and downregulation of β-adrenergic receptors. Th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707959/ https://www.ncbi.nlm.nih.gov/pubmed/34940604 http://dx.doi.org/10.3390/metabo11120846 |
_version_ | 1784622565518475264 |
---|---|
author | Kawaguchi, Satoshi Okada, Motoi |
author_facet | Kawaguchi, Satoshi Okada, Motoi |
author_sort | Kawaguchi, Satoshi |
collection | PubMed |
description | The mechanism of sepsis-induced cardiac dysfunction is believed to be different from that of myocardial ischemia. In sepsis, chemical mediators, such as endotoxins, cytokines, and nitric oxide, cause metabolic abnormalities, mitochondrial dysfunction, and downregulation of β-adrenergic receptors. These factors inhibit the production of ATP, essential for myocardial energy metabolism, resulting in cardiac dysfunction. This review focuses on the metabolic changes in sepsis, particularly in the heart. In addition to managing inflammation, interventions focusing on metabolism may be a new therapeutic strategy for cardiac dysfunction due to sepsis. |
format | Online Article Text |
id | pubmed-8707959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87079592021-12-25 Cardiac Metabolism in Sepsis Kawaguchi, Satoshi Okada, Motoi Metabolites Review The mechanism of sepsis-induced cardiac dysfunction is believed to be different from that of myocardial ischemia. In sepsis, chemical mediators, such as endotoxins, cytokines, and nitric oxide, cause metabolic abnormalities, mitochondrial dysfunction, and downregulation of β-adrenergic receptors. These factors inhibit the production of ATP, essential for myocardial energy metabolism, resulting in cardiac dysfunction. This review focuses on the metabolic changes in sepsis, particularly in the heart. In addition to managing inflammation, interventions focusing on metabolism may be a new therapeutic strategy for cardiac dysfunction due to sepsis. MDPI 2021-12-06 /pmc/articles/PMC8707959/ /pubmed/34940604 http://dx.doi.org/10.3390/metabo11120846 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kawaguchi, Satoshi Okada, Motoi Cardiac Metabolism in Sepsis |
title | Cardiac Metabolism in Sepsis |
title_full | Cardiac Metabolism in Sepsis |
title_fullStr | Cardiac Metabolism in Sepsis |
title_full_unstemmed | Cardiac Metabolism in Sepsis |
title_short | Cardiac Metabolism in Sepsis |
title_sort | cardiac metabolism in sepsis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707959/ https://www.ncbi.nlm.nih.gov/pubmed/34940604 http://dx.doi.org/10.3390/metabo11120846 |
work_keys_str_mv | AT kawaguchisatoshi cardiacmetabolisminsepsis AT okadamotoi cardiacmetabolisminsepsis |